|
WO2020102203A1
|
|
Treatment of autoimmune disorders, such as relapsing remitting multiple sclerosis and clinically isolated syndrome with biotin compositions
|
|
US2020078394A1
|
|
Treatment of autism and autism spectrum disorders with biotin compositions
|
|
CN110049758A
|
|
Pyridine carboxylic acid magnesium compositions and its application method
|
|
AU2017318672A1
|
|
Magnesium biotinate compositions and methods of use
|
|
US2018110817A1
|
|
Maca compositions and methods of use
|
|
US2017135969A1
|
|
Topical arginine-silicate-inositol for wound healing
|
|
US2017000809A1
|
|
Arginine silicate inositol for improving cognitive function
|
|
GB201800283D0
|
|
Chromium histidinate and chromium picolinate complexes
|
|
US2016263135A1
|
|
Arginine silicate for periodontal disease
|
|
US2016220581A1
|
|
Chromium compositions for the treatment or prevention of diabetic retinopathy
|
|
CA2828572A1
|
|
Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
|
|
EP3513790A1
|
|
Chromium complexes as enhancers of brain glucose transporters
|
|
CA3021932A1
|
|
Use of chromium histidinate for treatment of cardiometabolic disorders
|
